Want to see AU:IDX full AI Analyst Report?
Total Valuation
Integral Diagnostics Ltd. has a market cap or net worth of AU$876.20M. The enterprise value is AU$1.31K.
Market CapAU$876.20M
Enterprise ValueAU$1.31K
Share Statistics
Integral Diagnostics Ltd. has 373,066,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding373,066,530
Owned by Insiders0.31%
Owned by Institutions―
Financial Efficiency
Integral Diagnostics Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.48%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.48%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee258.65K
Profits Per Employee7.19K
Employee Count3,049
Asset Turnover0.54
Inventory Turnover181.31
Valuation Ratios
The current PE Ratio of Integral Diagnostics Ltd. is 38.7. Integral Diagnostics Ltd.’s PEG ratio is 0.12.
PE Ratio38.7
PS Ratio0.95
PB Ratio1.10
Price to Fair Value1.10
Price to FCF16.35
Price to Operating Cash Flow8.90
PEG Ratio0.12
Income Statement
In the last 12 months, Integral Diagnostics Ltd. had revenue of 788.62M and earned 21.93M in profits. Earnings per share was 0.06.
Revenue788.62M
Gross Profit168.55M
Operating Income67.65M
Pretax Income32.11M
Net Income21.93M
EBITDA141.99M
Earnings Per Share (EPS)0.06
Cash Flow
In the last 12 months, operating cash flow was 95.24M and capital expenditures -49.64M, giving a free cash flow of 45.60M billion.
Operating Cash Flow95.24M
Free Cash Flow45.60M
Free Cash Flow per Share0.12
Dividends & Yields
Integral Diagnostics Ltd. pays an annual dividend of AU$0.06, resulting in a dividend yield of 4.08%
Dividend Per ShareAU$0.06
Dividend Yield4.08%
Payout Ratio81.11%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-16.73%
50-Day Moving Average2.11
200-Day Moving Average2.23
Relative Strength Index (RSI)58.55
Average Volume (3m)1.17M
Important Dates
Integral Diagnostics Ltd. upcoming earnings date is Feb 16, 2027, TBA (Confirmed).
Last Earnings DateAug 24, 2026
Next Earnings DateFeb 16, 2027
Ex-Dividend Date―
Financial Position
Integral Diagnostics Ltd. as a current ratio of 0.67, with Debt / Equity ratio of 88.33%
Current Ratio0.67
Quick Ratio0.65
Debt to Market Cap0.49
Net Debt to EBITDA3.84
Interest Coverage Ratio2.03
Taxes
In the past 12 months, Integral Diagnostics Ltd. has paid 10.07M in taxes.
Income Tax10.07M
Effective Tax Rate0.31
Enterprise Valuation
Integral Diagnostics Ltd. EV to EBITDA ratio is 9.10, with an EV/FCF ratio of 28.32.
EV to Sales1.64
EV to EBITDA9.10
EV to Free Cash Flow28.32
EV to Operating Cash Flow13.56
Balance Sheet
Integral Diagnostics Ltd. has AU$51.29M in cash and marketable securities with AU$597.10M in debt, giving a net cash position of -AU$545.81M billion.
Cash & Marketable SecuritiesAU$51.29M
Total DebtAU$597.10M
Net Cash-AU$545.81M
Net Cash Per Share-AU$1.46
Tangible Book Value Per Share-AU$0.44
Margins
Gross margin is 21.40%, with operating margin of 8.58%, and net profit margin of 2.78%.
Gross Margin21.40%
Operating Margin8.58%
Pretax Margin4.07%
Net Profit Margin2.78%
EBITDA Margin18.01%
EBIT Margin8.58%
Analyst Forecast
The average price target for Integral Diagnostics Ltd. is AU$3.28, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$3.28
Price Target Upside40.71% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast25.73%
EPS Growth Forecast390.83%